Nature Reviews Drug Discovery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 91.2 | Q1 | 100.0% | 32.577 | Q1 | 100.0% |
| 2024 | 101.8 | Q1 | 100.0% | 30.506 | Q1 | 100.0% |
| 2023 | 122.7 | Q1 | 100.0% | 22.399 | Q1 | 100.0% |
| 2022 | 120.1 | Q1 | 100.0% | 19.423 | Q1 | 99.9% |
| 2021 | 112.3 | Q1 | 100.0% | 11.296 | Q1 | 99.8% |
| 2020 | — | — | 9.921 | Q1 | 99.7% | |
| 2019 | — | — | 7.018 | Q1 | 99.5% | |
| 2018 | — | — | 9.483 | Q1 | 99.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1474-1784
ISSN
1474-1776
country
GBcoverage
2002-2026